WORK Medical Technology (WOK) Cash & Equivalents (2023 - 2025)

WORK Medical Technology's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $4.1 million for Q3 2025.

• Quarterly Cash & Equivalents fell 37.65% year-over-year to $4.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4.1 million (down 37.65% YoY) and the FY2025 annual result came in at $4.1 million, down 37.65% from the prior year.
• Cash & Equivalents was $4.1 million for Q3 2025 at WORK Medical Technology, up from $2.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $6.6 million in Q3 2024 and bottomed at $1.6 million in Q3 2023.
• A 3-year average of $3.6 million and a median of $3.0 million in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents jumped 310.85% — and 2025, when it sank 37.65%.
• WORK Medical Technology's Cash & Equivalents stood at $1.6 million in 2023, then soared by 310.85% to $6.6 million in 2024, then plunged by 37.65% to $4.1 million in 2025.
• Business Quant data shows WOK's Cash & Equivalents at $4.1 million in Q3 2025, $2.0 million in Q1 2025, and $6.6 million in Q3 2024.